Eli Lilly & Co. (LLY)
1014.38
+20.74
(+2.09%)
USD |
NYSE |
Dec 11, 12:02
Eli Lilly Free Cash Flow: 6.436B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Adverum Biotechnologies, Inc. | -138.44M |
| Viking Therapeutics, Inc. | -224.58M |
| Moderna, Inc. | -2.663B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 8.836B |
| Cash from Investing (Quarterly) | -2.983B |
| Cash from Financing (Quarterly) | 531.00M |
| Free Cash Flow Per Share (Quarterly) | 6.706 |
| Free Cash Flow to Equity (Quarterly) | 3.425B |
| Free Cash Flow to Firm (Quarterly) | 6.166B |
| Free Cash Flow Yield | 0.70% |